Cardiac Event Monitor Markets: Market Shares, Strategies, and Forecasts, 2017 to 2023

$4200 - Single Copy or $8400 - Web Posting | Report # 27025999 | 416 Pages | 180 Tables and Figures | 2017


Qty
Authorize.net
  • Key Topics
  • Cardiac Event Monitoring
  • Postacute Care Co-ordination
  • Healthcare Reform Readmission
  • High Risk Heart Failure Patient
  • CHF
  • Congestive Heart Failure
  • Diabetes Treatment
  • Cardiac Event Recording
  • HIPAA Privacy and Security
  • Telemonitoring
  • Tele-monitoring
  • Cardiac Event Recorder
  • Cardiac Event Monitor
  • Implantable Event Monitor
  • Mobile Cardiac Telemetry MCT Monitor

YOU MUST HAVE THIS STUDY


LEXINGTON, Massachusetts (April 26, 2017) – WinterGreen Research announces that it has published a new module Cardiac Event Monitors: Market Shares, Strategies, and Forecasts, 2017 to 2023.  The 2017 study has 416 pages and 180 tables and figures.  Growth is based on implementation of devices that measure cardiac function over a period of a month, provide analytics within the device, and send alerts to  a physician. 

Consideration of cardiac event recorder forecasts indicate that markets at $1.1 billion in 2016 will reach $4.8 billion by 2023.  Growth comes as this technology is able to support the greater emphasis that is being put on early diagnosis and prevention of disease by the medical community as a whole.  Heart disease has been the number one killer of people, creating a need for more proactive and ongoing diagnosis made possible by increased use of the remote units extending medical care from the acute care setting to everyday modalities.  

Digitalization of healthcare is shifting value from devices per se to software and services.  Physicians are looking for new ways to proactively monitor and manage patient health.   The challenges of delivering patient cardiac care can only be met through new, more integrated forms of care delivery across the health continuum, with a shift away from a focus on acute care and late-stage interventions to continuing care delivery that is appropriate to the circumstance.

According to Susan Eustis, principal author of the study, “In an increasingly connected world, the convergence of vital signs technologies with cardiac event monitoring technologies is able to facilitate healthy living.  This fits very well with cardiac equipment vendor core strengths in professional healthcare and in consumer health and well-being.”

Disruptive technologies, disruptive services offerings change cardiac event recorder markets, clinicians are leveraging technology to save lives.  

A cardiac event recorder is a battery-powered portable miniature device.   Devices record heart's electrical activity (ECG) to detect presence of symptoms.   Event recorders can be a loop memory monitor and a symptom event monitor with newer devices containing internal analytics and the ability to notify a physician directly if an event is detected.  Cardiac event ambulatory monitors can detect arrhythmias and get people to treatment faster before it is too late.  Units are useful in the fight to correct congestive heart failure even after it has been initiated.

Shortness of breath is a common symptom of cardiac disease.  It is frequently misdiagnosed as a respiratory symptom or ignored by patients and is not even considered a symptom.  Detection of heart disease is supported with the newer cardiac event recorders.  Early treatment is essential and the technology is a vital aid in providing that treatment.

Other, newer technologies are emerging.  A vital signs patch supports continuous, non-invasive monitoring of EKG, Heart Rate, respiration rate, surface temperature, and arterial blood oxygen saturation.  The device is an easy-to-use sensor worn on a patient’s upper chest. It is intended to be used on adult patients in a clinical environment. 

The intended use group is adults 21 and above.   Units are prescribed by a physician or other qualified healthcare professional.  Upon activation and connectivity to the supporting system, the VSP provides automation and alerts of key vital signs via continuous wireless monitoring.  

Considerable interest and effort has been put into patch-based devices aimed at improving convenience for the patient and achieving better compliance.  MCT 1-lead patches have been developed.  Medtronic’s SEEQ device is such a unit.

BioTelemetry’s CardioNet MCOT and Preventice BodyGuardian Heart have devices.   The newer patch based devices rely on MCT technology, iRhythm, a US-based AECG specialist, is selling a somewhat differentiated patch, Zio XT.  Similar to Holter monitoring, the device can record arrhythmias.  

It can record 10 days of continuous data, which is retrieved after completion of the monitoring, ie not live transmission like in MCT.  Cardiologists would hardly be able to handle such large amounts of data, therefore iRhythm has developed proprietary algorithms, which provide summary reports.

Cardiac event monitor market forecasts, event recorder device, MCT device, and implantable recorders are charged for as services when the units are provided to patients in this manner.  Insurance reimbursement is many times a more favorable way to collect money from a service.  
The implantable segment of the overall cardiac event recording market goes from 58% of the total to 80% of the total.  It implantable devices are far more reliable and accurate than the electronic external devices.  

WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software.  The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, electronics.ca, and Thompson Financial.  It conducts its business with integrity.  

The increasingly global nature of science, technology and engineering is a reflection of the implementation of the globally integrated enterprise.  Customers trust wintergreen research to work alongside them to ensure the success of the participation in a particular market segment.

WinterGreen Research supports various market segment programs; provides trusted technical services to the marketing departments.  It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally.  These are all vital market research support solutions requiring trust and integrity.

Report Methodology

This is the 259th report in a series of market research reports that provide forecasts in communications, telecommunications, the internet, computer, software, and telephone equipment. The project leaders take direct responsibility for writing and preparing each report. They have significant experience preparing industry studies. Forecasts are based on primary research and proprietary databases. Forecasts reflect analysis of the market trends in the segment and related segments. Unit and dollar shipments are analyzed through consideration of dollar volume of each market participation in the segment. Market share analysis includes conversations with key customers of products, industry segment leaders, marketing directors, distributors, leading market participants, and companies seeking to develop measurable market share. Over 200 in-depth interviews are conducted for each report with a broad range of key participants and opinion leaders in the market segment.

About the Company

WinterGreen Research, founded in 1985, provides strategic market assessments in telecommunications, communications equipment, health care, and advanced computer technology. Industry reports focus on opportunities that will expand existing markets or develop major new markets. The reports assess new product and service positioning strategies, new and evolving technologies, and technological impact on products, services, and markets. Market shares are provided. Leading market participants are profiled, and their marketing strategies, acquisitions, and strategic alliances are discussed. The principals of WinterGreen Research have been involved in analysis and forecasting of international business opportunities in telecommunications and advanced computer technology markets for over 30 years.

About the Principal Authors

Ellen T. Curtiss, Technical Director, co-founder of WinterGreen Research, conducts strategic and market assessments in technology-based industries. Previously she was a member of the staff of Arthur D. Little, Inc., for 23 years, most recently as Vice President of Arthur D. Little Decision Resources, specializing in strategic planning and market development services. She is a graduate of Boston University and the Program for Management Development at Harvard Graduate School of Business Administration. She is the author of recent studies on worldwide telecommunications markets and the Top Ten Telecommunications market analysis and forecasts.

Susan Eustis, President, co-founder of WinterGreen Research, has done research in communications and computer markets and applications. She holds several patents in microcomputing and parallel processing. She is the author of recent studies of the Service Oriented Architecture (SOA) marketing strategies, Internet software, a study of Push to Talk Equipment, Worldwide Telecommunications Equipment, Top Ten Telecommunications, Digital Loop Carrier, Web Hosting, Business Process Management, Servers, Blades, the Mainframe as a Green Machine, and Application Server markets. Ms. Eustis is a graduate of Barnard College.

$4200 - Single Copy or $8400 - Web Posting | Report # 27025999 | 416 Pages | 180 Tables and Figures | 2017


Qty
Authorize.net